Characterisation of age-dependent beta cell dynamics in the male db/db mice

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Dalbøge, Louise S ^a   Almholt, Dorthe L C ^b   Neerup, Trine S R ^b   Vassiliadis, Efstathios ^a   Vrang, Niels ^a   Pedersen, Lars ^a   Fosgerau, Keld ^b   Jelsing, Jacob ^a  

^a Gubra ApS ^*  (Denmark)

^b Zealand Pharma AS   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN;

AGE; ANIMAL CELL; APOPTOSIS; ARTICLE; BETA CELL MASS; BLOOD SAMPLING; CELL PROLIFERATION; CELLULAR PARAMETERS; CONTROLLED STUDY; DIET RESTRICTION; DYNAMICS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; IMMUNOHISTOCHEMISTRY; INSULIN BLOOD LEVEL; ISLET NUMBER; MALE; MEAN ISLET MASS; METABOLIC PARAMETERS; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; STEREOLOGY; STRUCTURE ANALYSIS;

AGE FACTORS; ANIMALS; APOPTOSIS; BLOOD GLUCOSE; C-PEPTIDE; CELL PROLIFERATION; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; FASTING; INSULIN; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; MALE; MICE;

EID: 84891947782     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082813     Document Type: Article

References (59)

1. Shaw JE, Sicree RA, Zimmet PZ (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87:4-14. doi:10.1016/j.diabres.2009.10.007. PubMed: 19896746.
2. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ et al. (2011) National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 countryyears and 2.7 million participants. Lancet 378:31-40. doi:10.1016/S0140-6736 (11) 60679-X. PubMed: 21705069.
3. Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539-553. doi:10.1002/(SICI) 1096-9136 (199807) 15:7. PubMed: 9686693. (Pubitemid 28319935)
4. Weir GC, Bonner-Weir S (2004) Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes 53 Suppl 3:S16-S21. doi:10.2337/diabetes.53.suppl-3. S16. PubMed: 15561905. (Pubitemid 39564517)
5. Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444:840-846. doi: 10.1038/nature05482. PubMed: 17167471. (Pubitemid 46024990)
6. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA et al. (2003) Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102-110. doi:10.2337/diabetes.52.1.102. PubMed: 12502499. (Pubitemid 36042113)
7. Hanley SC, Austin E, Assouline-Thomas B, Kapeluto J, Blaichman J et al. (2010) {beta}-Cell mass dynamics and islet cell plasticity in human type 2 diabetes. Endocrinology 151:1462-1472. doi:10.1210/en. 2009-1277. PubMed: 20176718.
8. Rahier J, Guiot Y, Goebbels RM, Sempoux C, Henquin JC (2008) Pancreatic beta-cell mass in European subjects with type 2 diabetes. Diabetes Obes Metab 10 Suppl 4:32-42. doi:10.1111/j. 1463-1326.2008.00969.x. PubMed: 18834431.
9. Bernard-Kargar C, Ktorza A (2001) Endocrine pancreas plasticity under physiological and pathological conditions. Diabetes 50 Suppl 1:S30-S35. doi:10.2337/diabetes.50.2007. S30. PubMed: 11272194. (Pubitemid 32148212)
10. Sone H, Kagawa Y (2005) Pancreatic beta cell senescence contributes to the pathogenesis of type 2 diabetes in high-fat diet-induced diabetic mice. Diabetologia 48:58-67. doi:10.1007/s00125-004-1605-2. PubMed: 15624098. (Pubitemid 40174657)
11. Bonner-Weir S, Deery D, Leahy JL, Weir GC (1989) Compensatory growth of pancreatic beta-cells in adult rats after short-term glucose infusion. Diabetes 38:49-53. doi:10.2337/diabetes.38.1.49. PubMed: 2642434. (Pubitemid 19021816)
12. Kargar C, Ktorza A (2008) Anatomical versus functional beta-cell mass in experimental diabetes. Diabetes Obes Metab 10 Suppl 4:43-53. doi: 10.1111/j.1463-1326.2008.00886.x. PubMed: 18834432.
13. Poitout V, Robertson RP (2008) Glucolipotoxicity: fuel excess and betacell dysfunction. Endocr Rev 29:351-366. PubMed: 18048763. (Pubitemid 351679704)
14. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT et al. (1995) Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269:543-546. doi:10.1126/science.7624777. PubMed: 7624777.
15. Lee GH, Proenca R, Montez JM, Carroll KM, Darvishzadeh JG et al. (1996) Abnormal splicing of the leptin receptor in diabetic mice. Nature 379:632-635. doi:10.1038/379632a0. PubMed: 8628397. (Pubitemid 26053452)
16. Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X et al. (1996) Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 84:491-495. doi:10.1016/S0092-8674 (00) 81294-5. PubMed: 8608603. (Pubitemid 26060722)
17. Coleman DL (1978) Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 14:141-148. doi: 10.1007/BF00429772. PubMed: 350680. (Pubitemid 8286141)
18. Hummel KP, Dickie MM, Coleman DL (1966) Diabetes, a new mutation in the mouse. Science 153:1127-1128. doi:10.1126/science. 153.3740.1127. PubMed: 5918576.
19. Coleman DL, Hummel KP (1967) Studies with the mutation, diabetes, in the mouse. Diabetologia 3:238-248. doi:10.1007/BF01222201. PubMed: 4907142.
20. Wyse BM, Dulin WE (1970) The influence of age and dietary conditions on diabetes in the db mouse. Diabetologia 6:268-273. doi:10.1007/BF01212237. PubMed: 4914664.
21. Like AA, Chick WL (1970) Studies in the diabetic mutant mouse. I. Light microscopy and radioautography of pancreatic islets. Diabetologia 6:207-215. doi:10.1007/BF01212231. PubMed: 4914661.
22. Puff R, Dames P, Weise M, Göke B, Seissler J et al. (2011) Reduced proliferation and a high apoptotic frequency of pancreatic beta cells contribute to genetically-determined diabetes susceptibility of db/db BKS mice. Horm Metab Res 43:306-311. doi:10.1055/s-0031-1271817. PubMed: 21412687.
23. Kawasaki F, Matsuda M, Kanda Y, Inoue H, Kaku K (2005) Structural and functional analysis of pancreatic islets preserved by pioglitazone in db/db mice. Am J Physiol Endocrinol Metab 288:E510-E518. PubMed: 15522998. (Pubitemid 40250545)
24. Shimoda M, Kanda Y, Hamamoto S, Tawaramoto K, Hashiramoto M et al. (2011) The human glucagon-like peptide-1 analogue liraglutide preserves pancreatic beta cells via regulation of cell kinetics and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes. Diabetologia 54:1098-1108. doi:10.1007/s00125-011-2069-9. PubMed: 21340625.
25. Fosgerau K, Jessen L, Lind Tolborg J, Østerlund T, Schaeffer Larsen K et al. (2013) The novel GLP-1-gastrin dual agonist, ZP3022, increases beta-cell mass and prevents diabetes in db/db mice. Diabetes Obes Metab 15:62-71. doi:10.1111/j.1463-1326.2012.01676.x. PubMed: 22862961.
26. Zhao Z, Choi J, Zhao C, Ma ZA (2012) FTY720 normalizes hyperglycemia by stimulating beta-cell in vivo regeneration in db/db mice through regulation of cyclin D3 and p57 (KIP2). J Biol Chem 287:5562-5573. doi:10.1074/jbc. M111.305359. PubMed: 22194608.
27. Paulsen SJ, Vrang N, Larsen LK, Larsen PJ, Jelsing J (2010) Stereological assessment of pancreatic beta-cell mass development in male Zucker Diabetic Fatty (ZDF) rats: correlation with pancreatic betacell function. J Anat 217:624-630. doi:10.1111/j. 1469-7580.2010.01285.x. PubMed: 20807269.
28. Bock T, Pakkenberg B, Buschard K (2003) Increased islet volume but unchanged islet number in ob/ob mice. Diabetes 52:1716-1722. doi: 10.2337/diabetes.52.7.1716. PubMed: 12829638. (Pubitemid 36792462)
29. Boyce RW, Dorph-Petersen KA, Lyck L, Gundersen HJ (2010) Designbased stereology: introduction to basic concepts and practical approaches for estimation of cell number. Toxicol Pathol 38:1011-1025. doi:10.1177/ 0192623310385140. PubMed: 21030683.
30. Teague J, Gyte A, Peel JE, Young KC, Loxham SJ et al. (2011) Reversibility of hyperglycaemia and islet abnormalities in the high fatfed female ZDF rat model of type 2 diabetes. J Pharmacol Toxicol Methods 63:15-23. doi:10.1016/j.vascn. 2010.04.001. PubMed: 20398780.
31. Leiter EH, Coleman DL, Hummel KP (1981) The influence of genetic background on the expression of mutations at the diabetes locus in the mouse. III. Effect of H-2 haplotype and sex. Diabetes 30:1029-1034. doi:10.2337/diab.30.12.1029. PubMed: 7030828.
32. Hummel KP, Coleman DL, Lane PW (1972) The influence of genetic background on expression of mutations at the diabetes locus in the mouse. I. C57BL-KsJ and C57BL-6J strains. Biochem Genet 7:1-13. doi:10.1007/BF00487005. PubMed: 4557514.
33. Kanda Y, Shimoda M, Tawaramoto K, Hamamoto S, Tatsumi F et al. (2009) Molecular analysis of db gene-related pancreatic beta cell dysfunction; evidence for a compensatory mechanism inhibiting development of diabetes in the db gene heterozygote. Endocr J 56:997-1008. doi:10.1507/endocrj. K09E-028. PubMed: 19706988.
34. Bernard C, Berthault MF, Saulnier C, Ktorza A (1999) Neogenesis vs. apoptosis As main components of pancreatic beta cell ass changes in glucose-infused normal and mildly diabetic adult rats. FASEB J 13:1195-1205. PubMed: 10385610. (Pubitemid 29300365)
35. Topp BG, McArthur MD, Finegood DT (2004) Metabolic adaptations to chronic glucose infusion in rats. Diabetologia 47:1602-1610. doi: 10.1007/s00125-004- 1493-5. PubMed: 15349726. (Pubitemid 39371643)
36. Chick WL, Like AA (1970) Studies in the diabetic mutant mouse.
37. Physiological factors associated with alterations in beta cell proliferation. Diabetologia 6:243-251. doi:10.1007/BF01212233. PubMed: 5432353.
38. Rankin MM, Kushner JA (2009) Adaptive beta-cell proliferation is severely restricted with advanced age. Diabetes 58:1365-1372. doi: 10.2337/db08-1198. PubMed: 19265026.
39. Steil GM, Trivedi N, Jonas JC, Hasenkamp WM, Sharma A et al. (2001) Adaptation of beta-cell mass to substrate oversupply: enhanced function with normal gene expression. Am J Physiol Endocrinol Metab 280:E788-E796. PubMed: 11287362.
40. Milburn JL Jr., Hirose H, Lee YH, Nagasawa Y, Ogawa A et al. (1995) Pancreatic beta-cells in obesity. Evidence for induction of functional, morphologic, and metabolic abnormalities by increased long chain fatty acids. J Biol Chem 270:1295-1299. doi:10.1074/jbc.270.3.1295. PubMed: 7836394.
41. El-Assaad W, Buteau J, Peyot ML, Nolan C, Roduit R et al. (2003) Saturated fatty acids synergize with elevated glucose to cause pancreatic beta-cell death. Endocrinology 144:4154-4163. doi: 10.1210/en. 2003-0410. PubMed: 12933690. (Pubitemid 37088771)
42. Prentki M, Nolan CJ (2006) Islet beta cell failure in type 2 diabetes. J Clin Invest 116:1802-1812. doi:10.1172/JCI29103. PubMed: 16823478. (Pubitemid 44033300)
43. Poitout V, Amyot J, Semache M, Zarrouki B, Hagman D et al. (2010) Glucolipotoxicity of the pancreatic beta cell. Biochim Biophys Acta 1801:289-298. doi:10.1016/j.bbalip. 2009.08.006. PubMed: 19715772.
44. Maedler K, Spinas GA, Lehmann R, Sergeev P, Weber M et al. (2001) Glucose induces beta-cell apoptosis via upregulation of the Fas receptor in human islets. Diabetes 50:1683-1690. doi:10.2337/diabetes.50.8.1683. PubMed: 11473025. (Pubitemid 33641583)
45. Piro S, Anello M, Di Pietro C, Lizzio MN, Patanè G et al. (2002) Chronic exposure to free fatty acids or high glucose induces apoptosis in rat pancreatic islets: possible role of oxidative stress. Metabolism 51:1340-1347. doi:10.1053/meta.2002.35200. PubMed: 12370856. (Pubitemid 35174157)
46. Shimabukuro M, Zhou YT, Levi M, Unger RH (1998) Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. Proc Natl Acad Sci U S A 95:2498-2502. doi:10.1073/pnas.95.5.2498. PubMed: 9482914. (Pubitemid 28145970)
47. Medarova Z, Bonner-Weir S, Lipes M, Moore A (2005) Imaging betacell death with a near-infrared probe. Diabetes 54:1780-1788. doi: 10.2337/diabetes.54.6. 1780. PubMed: 15919800. (Pubitemid 40770768)
48. Kjørholt C, Akerfeldt MC, Biden TJ, Laybutt DR (2005) Chronic hyperglycemia, independent of plasma lipid levels, is sufficient for the loss of beta-cell differentiation and secretory function in the db/db mouse model of diabetes. Diabetes 54:2755-2763. doi:10.2337/diabetes.54.9.2755. PubMed: 16123366. (Pubitemid 41233599)
49. Maedler K, Sergeev P, Ris F, Oberholzer J, Joller-Jemelka HI et al. (2002) Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J Clin Invest 110:851-860. doi: 10.1172/JCI15318. PubMed: 12235117.
50. Xie J, Herbert TP (2012) The role of mammalian target of rapamycin (mTOR) in the regulation of pancreatic beta-cell mass: implications in the development of type-2 diabetes. Cell Mol Life Sci 69:1289-1304. doi:10.1007/s00018-011- 0874-4. PubMed: 22068611.
51. Maestre I, Jordán J, Calvo S, Reig JA, Ceña V et al. (2003) Mitochondrial dysfunction is involved in apoptosis induced by serum withdrawal and fatty acids in the beta-cell line INS-1. Endocrinology 144:335-345. doi:10.1210/en. 2001-211282. PubMed: 12488362. (Pubitemid 36076123)
52. Ma ZA, Zhao Z, Turk J (2012) Mitochondrial dysfunction and beta-cell failure in type 2 diabetes mellitus. Exp Diabetes Res 2012:703538
53. Dor Y, Brown J, Martinez OI, Melton DA (2004) Adult pancreatic betacells are formed by self-duplication rather than stem-cell differentiation. Nature 429:41-46. doi:10.1038/nature02520. PubMed: 15129273. (Pubitemid 38620543)
54. Meier JJ (2008) Beta cell mass in diabetes: a realistic therapeutic target? Diabetologia 51:703-713. doi:10.1007/s00125-008-0936-9. PubMed: 18317728.
55. de Koning EJ, Bonner-Weir S, Rabelink TJ (2008) Preservation of betacell function by targeting beta-cell mass. Trends Pharmacol Sci 29:218-227. doi:10.1016/j.tips.2008.02.001. PubMed: 18359095.
56. Yoon KH, Ko SH, Cho JH, Lee JM, Ahn YB et al. (2003) Selective betacell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea. J Clin Endocrinol Metab 88:2300-2308. doi: 10.1210/jc.2002-020735. PubMed: 12727989. (Pubitemid 36549911)
57. Saisho Y, Butler AE, Manesso E, Elashoff D, Rizza RA et al. (2013) beta-cell mass and turnover in humans: effects of obesity and aging. Diabetes Care 36:111-117. doi:10.2337/dcS13-2046. PubMed: 22875233.
58. Kahn SE (2013) Quantifying beta-cells in health and disease: the past, the present, and the need. Diabetes Care 36:4-5. doi:10.2337/dc12-1251. PubMed: 23264284.
59. Jurgens CA, Toukatly MN, Fligner CL, Udayasankar J, Subramanian SL et al. (2011) beta-cell loss and beta-cell apoptosis in human type 2 diabetes are related to islet amyloid deposition. Am J Pathol 178:2632-2640. doi:1 016/j.ajpath.2011.02.036. PubMed: 21641386.